Shares of Viatris Inc. VTRS advanced 1.19% to $11.06 Thursday, on what proved to be an all-around dismal trading session for ...
StockStory.org on MSN2d
3 Reasons to Sell VTRS and 1 Stock to Buy InsteadViatris’s stock price fell to $10.77. Shareholders have lost 9% of their capital, which is disappointing considering the S&P ...
NORTHAMPTON, MA / ACCESS Newswire / February 17, 2025 / By Adelina Nedelcu As Leo stands in his office, overseeing the ...
15d
Hosted on MSNViatris Stock Outlook: Is Wall Street Bullish or Bearish?Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in November 2020. Headquartered in Canonsburg, Pennsylvania, Viatris focuses on ...
Viatris, formed from Mylan and Pfizer's Established Brands, has faced stock price volatility since its inception in 2020. I rated Viatris a "Buy" last October, based on management's completion of ...
This was the stock's second consecutive day of losses.
StockStory.org on MSN1d
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The RestLet’s take a look at how generic pharmaceuticals stocks fared in Q3, starting with Amneal (NASDAQ:AMRX). The generic ...
James Headen Pfitzer, Senior Director, Global Policy, Corporate Affairs, Viatris and Melissa Mitchell, AMR IA Secretariat ...
NORTHAMPTON, MA / ACCESS Newswire / February 17, 2025 / By Adelina Nedelcu?As Leo stands in his office, overseeing the entrance of Viatris' bustling office in the Netherlands, he reflects on the 50 ye ...
James Headen Pfitzer, Senior Director, Global Policy, Corporate Affairs, Viatris and Melissa Mitchell, AMR IA Secretariat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results